P. Falkai, T. Wobruck, J. Lieberman, B. Glenthoj, W. Gattaz et al., World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Acute treatment of schizophrenia, The World Journal of Biological Psychiatry, vol.19, issue.3, pp.132-191, 2005.
DOI : 10.4088/JCP.v63n1002

A. Awad and L. Voruganti, The Burden of Schizophrenia on Caregivers, PharmacoEconomics, vol.29, issue.2, pp.149-162, 2008.
DOI : 10.2165/00019053-200826020-00005

P. Harvey, M. Green, R. Keefe, and D. Velligan, Cognitive Functioning in Schizophrenia, The Journal of Clinical Psychiatry, vol.65, issue.3, pp.361-372, 2004.
DOI : 10.4088/JCP.v65n0312

P. Harvey and A. Bellack, Toward a Terminology for Functional Recovery in Schizophrenia: Is Functional Remission a Viable Concept?, Schizophrenia Bulletin, vol.35, issue.2, pp.300-306, 2009.
DOI : 10.1093/schbul/sbn171

T. Burns and D. Patrick, Social functioning as an outcome measure in schizophrenia studies, Acta Psychiatrica Scandinavica, vol.25, issue.23, pp.403-418, 2007.
DOI : 10.1176/appi.ajp.160.3.582

D. Wiersma, J. Wanderling, E. Dragomirecka, K. Ganev, G. Harrison et al., Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres, Psychological Medicine, vol.30, issue.5, pp.1155-1167, 2000.
DOI : 10.1017/S0033291799002627

A. Bellack, M. Green, J. Cook, W. Fenton, P. Harvey et al., Assessment of Community Functioning in People With Schizophrenia and Other Severe Mental Illnesses: A White Paper Based on an NIMH-Sponsored Workshop, Schizophrenia Bulletin, vol.33, issue.3, pp.805-822, 2007.
DOI : 10.1093/schbul/sbl035

G. Bond and R. Drake, Predictors of competitive employment among patients with schizophrenia, Current Opinion in Psychiatry, vol.21, issue.4, pp.362-369, 2008.
DOI : 10.1097/YCO.0b013e328300eb0e

R. Rosenheck, D. Leslie, R. Keefe, J. Mcevoy, M. Swartz et al., Barriers to Employment for People With Schizophrenia, American Journal of Psychiatry, vol.163, issue.3, pp.411-417, 2006.
DOI : 10.1176/appi.ajp.163.3.411

G. Juckel and P. Morosini, The new approach: psychosocial functioning as a necessary outcome criterion for therapeutic success in schizophrenia, Current Opinion in Psychiatry, vol.21, issue.6, pp.630-639, 2008.
DOI : 10.1097/YCO.0b013e328314e144

H. Nasrallah and R. Lasser, Improving patient outcomes in schizophrenia: achieving remission, Journal of Psychopharmacology, vol.20, issue.6 suppl, pp.57-61, 2006.
DOI : 10.1177/1359786806071248

J. Ventura, K. Subotnik, L. Guzik, G. Hellemann, M. Gitlin et al., Remission and recovery during the first outpatient year of the early course of schizophrenia, Schizophrenia Research, vol.132, issue.1, pp.18-23, 2011.
DOI : 10.1016/j.schres.2011.06.025

A. European-medicines, Draft Guideline 'Clinical Investigation of Medicinal Products in the Treatment of Schizophrenia, 2011.

P. Gorwood and J. Peuskens, European Group On Functional Outcomes, Remission in Schizophrenia: Setting new standards in schizophrenia outcomes: symptomatic remission 3 years before versus after the Andreasen criteria, Eur Psychiatry, vol.2012, issue.27, pp.170-175

G. Pandina, J. Lindenmayer, J. Lull, P. Lim, S. Gopal et al., P a l u m b oJ :A randomized, placebo-controlled study to assess the efficacy and safety of 3 doses of paliperidone palmitate in adults with acutely exacerbated schizophrenia, pp.235-244, 2010.

R. Kahn, W. Fleischhacker, H. Boter, M. Davidson, Y. Vergouwe et al., Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial, The Lancet, vol.371, issue.9618, pp.1085-1097, 2008.
DOI : 10.1016/S0140-6736(08)60486-9

J. Olivares, A. Rodriguez-morales, J. Diels, M. Povey, A. Jacobs et al., Longterm outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR) Eur Psychiatry, pp.287-296, 2009.

J. Jang, N. Shin, G. Shim, H. Park, E. Kim et al., Longitudinal Patterns of Social Functioning and Conversion to Psychosis in Subjects at Ultra-High Risk, Australian & New Zealand Journal of Psychiatry, vol.96, issue.9, pp.763-770, 2011.
DOI : 10.1111/j.2044-8341.1959.tb00467.x

J. Kane, F. Canas, M. Kramer, L. Ford, C. Gassmann-mayer et al., Treatment of schizophrenia with paliperidone extended-release tablets: A 6-week placebo-controlled trial???, Schizophrenia Research, vol.90, issue.1-3, pp.147-161, 2007.
DOI : 10.1016/j.schres.2006.09.012

A. Mortimer, S. Martin, H. Lôo, J. Peuskens, . Solianol-study et al., A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia, International Clinical Psychopharmacology, vol.19, issue.2, pp.63-69, 2004.
DOI : 10.1097/00004850-200403000-00002

R. Kern, S. Glynn, W. Horan, and S. Marder, Psychosocial Treatments to Promote Functional Recovery in Schizophrenia, Schizophrenia Bulletin, vol.35, issue.2, pp.347-361, 2009.
DOI : 10.1093/schbul/sbn177

V. Roder, D. Mueller, and S. Schmidt, Effectiveness of Integrated Psychological Therapy (IPT) for Schizophrenia Patients: A Research Update, Schizophrenia Bulletin, vol.37, issue.suppl 2, pp.71-79, 2011.
DOI : 10.1093/schbul/sbr072

P. Grant, G. Huh, D. Perivoliotis, N. Stolar, and A. Back, Randomized Trial to Evaluate the Efficacy of Cognitive Therapy for Low-Functioning Patients With Schizophrenia, Archives of General Psychiatry, vol.69, issue.2, pp.121-127, 2012.
DOI : 10.1001/archgenpsychiatry.2011.129

W. Fleischhacker, J. Rabinowitz, G. Kemmler, M. Eerdekens, and A. Mehnert, Perceived functioning, well-being and psychiatric symptoms in patients with stable schizophrenia treated with long-acting risperidone for 1 year, The British Journal of Psychiatry, vol.187, issue.2, pp.131-136, 2005.
DOI : 10.1192/bjp.187.2.131

L. San, A. Ciudad, E. Alvarez, J. Bobes, and J. Gilaberte, Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: Prevalence and associations in a cross-sectional study, European Psychiatry, vol.22, issue.8, pp.490-498, 2007.
DOI : 10.1016/j.eurpsy.2007.06.005

J. Huppert, K. Weiss, R. Lim, S. Pratt, and T. Smith, Quality of life in schizophrenia: contributions of anxiety and depression, Schizophrenia Research, vol.51, issue.2-3, pp.171-180, 2001.
DOI : 10.1016/S0920-9964(99)00151-6

J. Docherty, C. Bossie, B. Lachaux, P. Bouhours, Y. Zhu et al., Patient-based and clinician-based support for the remission criteria in schizophrenia, Int Clin Psychopharmacol, vol.22, pp.51-55, 2007.

M. Lambert, B. Schimmelmann, D. Naber, F. Eich, H. Schulz et al., Early- and Delayed Antipsychotic Response and Prediction of Outcome in 528 Severely Impaired Patients with Schizophrenia Treated with Amisulpride, Pharmacopsychiatry, vol.42, issue.06, pp.277-283, 2009.
DOI : 10.1055/s-0029-1234105

L. De-haan, L. Nimwegen, T. Amelsvoort, P. Dingemans, and D. Linszen, Improvement of Subjective Well-being and Enduring Symptomatic Remission, A 5-Year Follow-up of First Episode Schizophrenia, Pharmacopsychiatry, vol.41, issue.04, pp.125-128, 2008.
DOI : 10.1055/s-2008-1076729

A. Karow, D. Naber, M. Lambert, S. Moritz, and . Egofors-initiative, Remission as perceived by people with schizophrenia, family members and psychiatrists, European Psychiatry, vol.27, issue.6, pp.401-405, 2012.
DOI : 10.1016/j.eurpsy.2011.01.013

P. Llorca, C. Lançon, S. Lancrenon, F. Bayle, H. Caci et al., The ???Functional Remission of General Schizophrenia??? (FROGS) scale: Development and validation of a new questionnaire, Schizophrenia Research, vol.113, issue.2-3, pp.218-225, 2009.
DOI : 10.1016/j.schres.2009.04.029

J. Endicott, R. Spitzer, J. Fleiss, and J. Cohen, The Global Assessment Scale, Archives of General Psychiatry, vol.33, issue.6, pp.766-771, 1976.
DOI : 10.1001/archpsyc.1976.01770060086012

P. Morosini, L. Magliano, L. Brambilla, S. Ugolini, and R. Pioli, Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning, Acta Psychiatr Scand, vol.101, pp.323-329, 2000.

S. Brissos, A. Molodynski, V. Dias, and M. Figueira, The importance of measuring psychosocial functioning in schizophrenia, Annals of General Psychiatry, vol.10, issue.1, p.18, 2011.
DOI : 10.1176/appi.ajp.163.11.1918

V. Balanzá, J. Bobes, C. Fernando, P. García, M. Martinez et al., La funcionalidad en el paciente con trastorno mental grave: una encuesta de opinion entre psiquiatras españoles, Rev Psiquiatr Salud Ment, issue.4 1, pp.1-8, 2011.

L. Helldin, J. Kane, U. Karilampi, T. Norlander, and T. Archer, Remission in prognosis of functional outcome: A new dimension in the treatment of patients with psychotic disorders, Schizophrenia Research, vol.93, issue.1-3, pp.160-168, 2007.
DOI : 10.1016/j.schres.2007.01.014

P. Buckley, P. Harvey, C. Bowie, and A. Loebel, The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone, Schizophrenia Research, vol.94, issue.1-3, pp.99-106, 2007.
DOI : 10.1016/j.schres.2006.12.032

J. Peuskens, P. Gorwood, and . Egofors-initiative, How are we assessing functioning in schizophrenia? A need for a consensus approach, European Psychiatry, vol.27, issue.6, pp.391-395, 2011.
DOI : 10.1016/j.eurpsy.2011.02.013

D. Schaub, M. Brüne, E. Jaspen, F. Pajonk, H. Bierhoff et al., The illness and everyday living: close interplay of psychopathological syndromes and psychosocial functioning in chronic schizophrenia, European Archives of Psychiatry and Clinical Neuroscience, vol.258, issue.1, pp.85-93, 2011.
DOI : 10.1007/s00406-010-0122-1

M. Lambert and D. Naber, Current Issues in Schizophrenia, CNS Drugs, vol.33, issue.Supplement 2, pp.5-17, 2004.
DOI : 10.2165/00023210-200418002-00002

R. Hunter and S. Barry, Negative symptoms and psychosocial functioning in schizophrenia: Neglected but important targets for treatment, European Psychiatry, vol.27, issue.6, pp.432-436, 2012.
DOI : 10.1016/j.eurpsy.2011.02.015

M. Figueira and S. Brissos, Measuring psychosocial outcomes in schizophrenia patients, Current Opinion in Psychiatry, vol.24, pp.91-99, 2011.
DOI : 10.1097/YCO.0b013e3283438119